About Ivenix
Ivenix is a company based in Amesbury (United States) founded in 2001 was acquired by Fresenius Kabi in March 2022.. Ivenix has raised $159.97 million across 9 funding rounds from investors including Eight Roads Ventures, 6 Dimensions Capital and F-Prime Capital. The company has 60 employees as of December 31, 2022. Ivenix offers products and services including Ivenix Infusion System and Large Volume Pump. Ivenix operates in a competitive market with competitors including Assurex Health, 410 Medical, Hospira, Hygieia and Belmont Medical Technologies, among others.
- Headquarter Amesbury, United States
- Employees 60 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ivenix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$159.97 M (USD)
in 9 rounds
-
Latest Funding Round
$50 M (USD), Series E
Mar 17, 2017
-
Investors
Eight Roads Ventures
& 7 more
-
Employee Count
60
as on Dec 31, 2022
-
Acquired by
Fresenius Kabi
(Mar 31, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ivenix
Ivenix offers a comprehensive portfolio of products and services, including Ivenix Infusion System and Large Volume Pump. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers accurate fluid control for intravenous administration
Enables precise flow measurement in clinical environments
Funding Insights of Ivenix
Ivenix has successfully raised a total of $159.97M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $50 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $50.0M
-
First Round
First Round
(31 Jul 2009)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Series E - Ivenix | Valuation |
investors |
|
| Sep, 2015 | Amount | Series D - Ivenix | Valuation | 6 Dimensions Capital | |
| Aug, 2011 | Amount | Series C - Ivenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ivenix
Ivenix has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Eight Roads Ventures, 6 Dimensions Capital and F-Prime Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in early stage companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ivenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ivenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ivenix Comparisons
Competitors of Ivenix
Ivenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Assurex Health, 410 Medical, Hospira, Hygieia and Belmont Medical Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| domain | founded_year | HQ Location |
Rapid infusion systems are provided for critically ill patients.
|
|
| domain | founded_year | HQ Location |
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| domain | founded_year | HQ Location |
Fluid management and critical care medical devices are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ivenix
Frequently Asked Questions about Ivenix
When was Ivenix founded?
Ivenix was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Where is Ivenix located?
Ivenix is headquartered in Amesbury, United States. It is registered at Amesbury, Massachusetts, United States.
Who is the current CEO of Ivenix?
Stuart Randle is the current CEO of Ivenix.
Is Ivenix a funded company?
Ivenix is a funded company, having raised a total of $159.97M across 9 funding rounds to date. The company's 1st funding round was a Series C of $25M, raised on Jul 31, 2009.
How many employees does Ivenix have?
As of Dec 31, 2022, the latest employee count at Ivenix is 60.
What does Ivenix do?
Ivenix was founded in 2001 in Amesbury, United States, within the healthcare technology sector. Infusion management systems are provided, integrating information systems into infusion devices. Wireless, web-based architecture is used to connect pumps attached to patients. Remote dashboards are accessed by nurses, pharmacists, and clinical engineers for decision support. Pump data across organizations is analyzed for quality and efficiency improvements. FDA review remains pending.
Who are the top competitors of Ivenix?
Ivenix's top competitors include 410 Medical, Belmont Medical Technologies and Hospira.
What products or services does Ivenix offer?
Ivenix offers Ivenix Infusion System and Large Volume Pump.
Who are Ivenix's investors?
Ivenix has 8 investors. Key investors include Eight Roads Ventures, 6 Dimensions Capital, F-Prime Capital, Cardinal Partners, and Easterly Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.